Bupropion Hydrochloride
- Product NDC
- 42291-182
- 11-digit product format
- 422910182
- Labeler code
- 42291
- Product ID
- 42291-182_ed9c413c-f831-a4d4-e053-2a95a90a9d93
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA077284
- Marketing category
- ANDA
- Marketing start
- 2022-11-16
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-182-30 | 42291018230 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42291-182-30) | 2022-11-16 | 0000-00-00 | No | No | Current |
| 42291-182-50 | 42291018250 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42291-182-50) | 2022-11-16 | 0000-00-00 | No | No | Current |